We present a technique of retrosternal block for symptomatic treatment for dyspnoea of various aetiologies. In our experience with 20 patients, a retrosternal block using lignocaine improved symptoms within minutes. The block was easy to perform and was helpful when the patients' symptoms were not relieved by conventional therapy. Prospective controlled studies are needed to further assess this simple and promising treatment.
Dyspnoea is a subjective sensation of abnormally uncomfortable awareness of breathing 1 , associated with shortness of breath, that appears in a variety of physiologic and pathologic medical conditions 2 . Treatment is aimed at the underlying disorder causing the symptoms. Unfortunately, elimination of the causative factor is not possible in many cases, and only partially effective in others. If dyspnoea persists despite maximal medical treatment, the management is symptomatic. Treatment includes supplemental oxygen, inhaled bronchodilators, corticosteroids and various drugs including theophylline or sedatives. Respiratory muscle training, chest physiotherapy and breathing techniques have been suggested 3 . Cervical and high thoracic epidural blocks have been reported to be of some use 4, 5 . We describe our experience with a different modality -the retrosternal block. This technique was first described in the Russian literature as a treatment for cardiac angina [6] [7] [8] [9] . Later it was found to be successful in severe bronchial asthma 10 . We applied this technique to dyspnoeic patients with various etiologies. Examples of our use of this technique are presented in the following two cases.
CASE HISTORIES

Case 1
A 48-year-old woman presented with an acute exacerbation of chronic obstructive lung disease. She was restless, cyanotic, sitting up in bed and using accessory muscles of respiration. Suprasternal and intercostal retractions were noted. She was coughing and wheezing. Oxygen supplementation by nasal cannula and full bronchodilator therapy with terbutaline and ipratropium bromide by inhalation and intravenous hydrocortisone did not relieve her distress. Her vital signs were: heart rate (HR) 118 beats/ minute, blood pressure (BP) 152/90 mmHg, respiratory rate (RR) 28 breaths/minute and oxygen saturation (SpO 2 ) 88%. After explanation and patient consent, a retrosternal block using 1% lignocaine 40 ml was performed. A few minutes later, the patient became less distressed. She was breathing freely, without apparent muscular effort, and was no longer anxious. Her vital signs at that time were: HR 100 beats/minute, BP 125/70 mmHg, RR 18 and SpO 2 94%. The effect of treatment persisted over several hours, during which the conventional therapy was continued. The patient remained stable without deterioration, until her discharge from the emergency room on the same day.
Case 2
A 65-year-old man with a medical history of congestive heart failure that was treated with diuretics, digoxin, and an angiotensin-converting enzyme inhibitor, presented to the emergency room with cough, shortness of breath, dyspnoea at rest, and fatigue. Cyanosis of lips and fingers, as well as pedal oedema, were noted. Auscultation revealed crackles at the base of both lungs. His vital signs were: HR 98 beats/minute, BP 120/75 mmHg, RR 24 breaths/ minute and SpO 2 86%. Oxygen supplementation by face mask and intravenous treatment with frusemide and morphine were started. Although the patient showed overall improvement, his cough and dyspnoea persisted. After obtaining informed consent, a retrosternal block with 1% lignocaine 40 ml was performed. Within 15 minutes, his pulmonary symptoms subsided; his HR was 85 beats/minute, BP was 110/70 and SpO 2 improved to 95%. After several hours of observation he was discharged from the emergency room free of respiratory complaints.
We have now performed retrosternal blocks for treatment of dyspnoea on 20 patients. We found that the response to the block starts within 5 to 15 minutes. We have had no complications so far, such as intravascular injection, local anaesthetic toxicity, pneumothorax, or pneumomediastinum. It is difficult to determine the exact duration of the beneficial effect of the block, since dyspnoea did not recommence in those patients on the day of treatment.
Retrosternal Block Technique
The study was approved by the Ethics Committee of Rambam Medical Center Institution. Informed patient consent was obtained. Under monitoring with noninvasive blood pressure, electrocardiogram and pulseoximeter, intravenous access, if not already established, is achieved. The suprasternal region is cleansed with aseptic solution. A standard 21-gauge, 5 cm-long injection needle is sterilely bent at its middle to create a 60° angle. The needle is introduced into the middle of the sternal notch, under and adjacent to the bony structure of the sternum, about 2 cm caudally (Figure 1) . A hanging-drop technique (a saline drop at the proximal opening of the needle) is used to identify accidental entry into the negative pressure pleural space if the drop is sucked in. A syringe is attached, and meticulous aspiration is performed to ensure that no blood vessel has been penetrated. A test dose of 3 ml of the preferred local anaesthetic solution is injected, and afterwards 35 to 50 ml (5-10 ml for a child) is slowly added, repeatedly checking by aspiration that the needle has not entered a blood vessel. It is important not to exceed a safe total dose of lignocaine (5 mg/kg). Following the procedure the patient is observed for arrhythmias, hypotension, and worsening respiratory state. A high index of suspicion for pneumothorax is maintained.
DISCUSSION
Dyspnoea is a common symptom in patients with cardiopulmonary disease, such as asthma, chronic obstructive lung disease, pulmonary embolism, pulmonary oedema and many other aetiologies 1 . Dyspnoea is a subjective symptom, thus it may be a complaint of a patient with an apparently normal breathing pattern. On the other hand, there are situations in which breathing appears laboured, but dyspnoea does not occur, such as hyperventilation associated with metabolic acidaemia 1 . Several pathophysiologic mechanisms may explain this symptom. Hypercapnia and hypoxaemia stimulate chemoreceptors and cause air hunger to the patient. Pulmonary stretch receptors in the upper and lower airway are sensitive to lung inflation, and C fibres in alveolar wall and blood vessels respond to interstitial congestion 3 . Receptors in the muscles, tendons and joints of the chest wall also influence the pattern of breathing and sensation of dyspnoea. Clinical studies using healthy volunteers and patients with chronic lung disease demonstrated reduced dyspnoea by the use of a physiotherapeutic vibrator over the parasternal intercostal muscles 11, 12 , which changes the signals from chest wall to the brain and modifies the central perception of dyspnoea. The relief of dyspnoea following retrosternal block may be achieved via the same mechanism. Another possible explanation is a direct inhibitory effect on the autonomic parasympathetic cholinergic nerve supply of the airways and lungs 13, 14 . The pharmacologic effect of the local anaesthetic may be relevant as well. The systemic absorption of 300-400 mg lignocaine from the vascularized upper mediastinum can cause attenuation of bronchial hyperreactivity, reduce minute ventilation, and induce drowsiness [15] [16] [17] . The dyspnoeic patient is often anxious and disturbed, and the addition of mild sedation may be beneficial.
In our experience, the retrosternal block provides rapid amelioration of dyspnoea of various origins and aetiologies, such as asthma, chronic obstructive lung disease and pulmonary oedema. We have noticed that not only is dyspnoea relieved, but the ability to cough and remove airway secretions is also more efficient, suggesting improved airway mechanics. The retrosternal block can be performed in the emergency room, ward or clinic, provided that basic monitoring and resuscitative equipment, oxygen and drugs are available. The volume of injected local anaesthetic is important. Our experience has shown that between 35 and 50 ml (<5 ml/kg) are sufficient to obtain the desired results. Higher volumes might not provide better response and could lead to greater risk of sideeffects. Contraindications to performing the block are patient refusal, known sensitivity to local anaesthetics, infection of skin at the point of injection, and coagulation abnormalities.
Possible serious complications are pneumothorax or pneumomediastinum. It is important to keep in mind that hyperinflation is frequently seen in patients with the symptoms of dyspnoea, and the lungs can cross the midline retrosternally at the jugular notch in cases of severe air trapping. Other complications include intravascular injection of the local anaesthetic, manifested as cardiovascular depression, central nervous system irritability and convulsions, the occurrence of cardiac arrhythmias due to interference with the autonomic nerve supply, infection, and haematoma. The technique as described above, together with slow injection rate of the local anaesthetic and close observation of the clinical signs should lessen the risk of complications.
We present our experience of the retrosternal block as an effective additive to the armamentarium of dyspnoea management. A prospective controlled study, to measure objective and subjective parameters is needed to further assess this simple and promising treatment.
